Click here to register for and view this on-demand webcast. Registration is free!
Molecular testing has revolutionized screening for cervical cancer, and new developments in this area are changing the way clinicians approach the screening process. New data from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) clinical trial spurred the FDA to recently approve for the first time an HPV DNA testing algorithm for women 25 and older as a primary screen for cervical cancer, and this approval will likely have an impact on guideline development moving forward. For now, though, what are the best practices for cervical cancer screening?
During this 60-minute FREE webinar, supported by an educational grant from Roche Diagnostics, Mark H. Stoler, MD, will discuss current thinking on primary screening for cervical cancer. You will know:
- What data from the ATHENA trial tell us about various methods used to perform cervical cancer screening
- What the current guidelines for cervical cancer screening are and how they predict risk
- What it means to have a "clinically validated" HPV test
- The advantages and limitations of using today's FDA-cleared HPV testing technologies
Mark H. Stoler, MD, Professor (Emeritus) of Pathology, Cytology and Gynecology; and Director, Gynecological Pathology Fellowship Program, University of Virginia, Charlottesville, VA
Dr. Stoler is an internationally recognized expert in Cytopathology, Gynecologic pathology and HPV biology. He received his initial training in pathology at the University of Rochester where he also received his undergraduate and medical school training. Following a specialized fellowship consisting of both surgical and cytopathology as well as molecular biology, he was appointed to the faculty of the University of Rochester from 1985-1989. In 1989, he moved to the Cleveland Clinic Foundation where he served as Staff Pathologist and the Medical Director of the Histology Laboratory. In 1993, Dr. Stoler was recruited to the University of Virginia. Dr. Stoler is the author or co-author of over 177 peer-reviewed publications and several book chapters. He is editor-in-chief of both Diagnostic Molecular Pathology, and the International Journal of Gynecological Pathology and is an Associate Editor for the 4th Edition of Sternberg's Diagnostic Surgical Pathology, the leading textbook of surgical pathology.
Laboratory administrators, directors, and managers; cytopathologists; molecular pathologists; clinicians; and IVD industry professionals involved in cervical cancer screening or HPV testing.
To access this webcast, you will need a computer with Internet access and speakers, a compatible Internet browser (e.g., Internet Explorer), and a compatible version of the Flash plug-in. To see if your browser, Flash plug-in and system meet the minimum requirements please visit the Adobe System Requirements page.